← Return to ARPI use after radiation treatment may be an issue

Discussion
Jeff Marchi avatar

ARPI use after radiation treatment may be an issue

Prostate Cancer | Last Active: 45 minutes ago | Replies (21)
Comment receiving replies
Profile picture for xahnegrey40 @xahnegrey40

@jeffmarc
"Len Who wrote the article commented on the fact that Darolutamide Results were almost the same as placebo results, Much better than the other two drugs"...

I am a bit confused by this statement...

Nubeqa results almost the same as a placebo - then "much better than the other two drugs" ??

Jump to this post

Replies to "@jeffmarc "Len Who wrote the article commented on the fact that Darolutamide Results were almost the..."
Jeff Marchi | @jeffmarc | 22 hours ago

@xahnegrey40
The incidents of Cancer cell growth from Darolutamide was much lower than from Enzalutamide or apalutamide. Close to the amount of growth with just a placebo.

Check out the graph I included At the bottom of the article.

VIEW AND REPLY